The differential diagnosis in patients with endogenous insulin-mediated hypoglycemia includes insulinoma, NIPHS, oral hypoglycemic agent-induced hypoglycemia, and insulin autoimmune hypoglycemia. The gene discussed is INS; the disease is pancreatic insulinoma.